What this market covers
Cell and gene therapy treats disease by giving engineered cells or by changing a patient's genes. Products include CAR T therapies and viral vector based treatments.
Typical segments
- CAR T cell therapies
- Gene replacement therapies
- Gene editing therapies
- Stem cell therapies
Source: Eurostat
Why this market is moving now
- Extra-EU import value moved +249% from 2022 to 2025, a direct read on EU demand for sourced supply.
- Supply is concentrated: one country provided a large share of extra-EU imports in 2025.
- US employment in the core industry shifted +23% since 2020.
- Clinical research is active, with studies recruiting now.
Key figures
Each figure names the source it came from. Open the source list below to read the quoted line.
| Figure | Value | Year | Source |
|---|---|---|---|
| The EU imported €662.9 million of products under CN code 30025100 (Cell therapy products) from outside the EU in 2025. | 662.9 EUR million | 2025 | Eurostat |
| Extra-EU imports of CN 30025100 were up 249% in 2025 compared with 2022 (€190.1 million), calculated from Eurostat values. | +249 % change | 2025 | Eurostat |
| EU exports of CN 30025100 to countries outside the EU were worth €314.0 million in 2025. | 314.0 EUR million | 2025 | Eurostat |
| Trade between EU member states in CN 30025100 (intra-EU arrivals) came to €450.6 million in 2025. | 450.6 EUR million | 2025 | Eurostat |
| United States was the largest non-EU supplier of CN 30025100 to the EU in 2025, with €490.6 million, or 74% of extra-EU imports. | 490.6 EUR million | 2025 | Eurostat |
| EU exports of CN 30025100 to the United States were €43.4 million in 2025. | 43.4 EUR million | 2025 | Eurostat |
| The average value of extra-EU imports of CN 30025100 was €10,949.99 per kilogram in 2025, calculated from Eurostat value and weight. | 10,949.99 EUR per kg | 2025 | Eurostat |
| Netherlands was the largest EU exporter of CN 30025100 to non-EU countries in 2025, at €237.3 million. | 237.3 EUR million | 2025 | Eurostat |
| The EU had 3,116 enterprises in NACE class C2120 (Manufacture of pharmaceutical preparations) in 2023. | 3,116 enterprises | 2023 | Eurostat |
| EU enterprises in NACE class C2120 had net turnover of €428.65 billion in 2023. | 428.65 EUR billion | 2023 | Eurostat |
| NACE class C2120 employed 600,730 people across the EU in 2023. | 600,730 persons employed | 2023 | Eurostat |
| The US had 830 private establishments in NAICS 325414 (Biological product (except diagnostic) manufacturing) in 2025. | 830 establishments | 2025 | U.S. Bureau of Labor Statistics |
| NAICS 325414 employed an average of 46,853 people in US private industry in 2025. | 46,853 jobs | 2025 | U.S. Bureau of Labor Statistics |
| US employment in NAICS 325414 changed by +23% between 2020 (38,064 jobs) and 2025, calculated from BLS figures. | +23 % change | 2025 | U.S. Bureau of Labor Statistics |
| Average annual pay in US NAICS 325414 was $124,162 in 2025. | 124,162 USD per year | 2025 | U.S. Bureau of Labor Statistics |
| ClinicalTrials.gov lists 2,011 registered studies for the condition "gene therapy". | 2,011 registered studies | 2026 | U.S. National Library of Medicine |
| 377 of those studies were recruiting participants when checked in November 2026. | 377 recruiting studies | 2026 | U.S. National Library of Medicine |
| PubMed indexed 118 papers mentioning "cell and gene therapy" in the title or abstract in 2025. | 118 papers | 2025 | U.S. National Library of Medicine |
Sources and method
The figures on this page come from the public sources listed below. Read how we work.
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
Quoted lines
- Figure 1
DS-045409, reporter EU27_2020, product 30025100, partner EXT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 662868676
- Figure 2
DS-045409, reporter EU27_2020, product 30025100, flow import, 2022 VALUE_IN_EUROS 190083772; 2025 VALUE_IN_EUROS 662868676
- Figure 3
DS-045409, reporter EU27_2020, product 30025100, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 313986148
- Figure 4
DS-045409, reporter EU27_2020, product 30025100, partner INT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 450600631
- Figure 5
DS-045409, reporter EU27_2020, product 30025100, partner US, flow import, 2025, VALUE_IN_EUROS 490623860
- Figure 6
DS-045409, reporter EU27_2020, product 30025100, partner US, flow export, 2025, VALUE_IN_EUROS 43422924
- Figure 7
DS-045409, reporter EU27_2020, product 30025100, flow import, 2025, VALUE_IN_EUROS 662868676, QUANTITY_IN_100KG 605
- Figure 1
- Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
Quoted lines
- Figure 8
DS-045409, reporter NL, product 30025100, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 237289362
- Figure 8
- Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
Quoted lines
- Figure 9
sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs ENT_NR, 2023, 3116
- Figure 10
sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs NETTUR_MEUR, 2023, 428651
- Figure 11
sbs_ovw_act, geo EU27_2020, nace_r2 C2120, indic_sbs EMP_NR, 2023, 600730
- Figure 9
- U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 325414, 2025 (2026-11-04)
Quoted lines
- Figure 12
QCEW 2025 annual, US000, private, NAICS 325414, annual_avg_estabs 830
- Figure 13
QCEW 2025 annual, US000, private, NAICS 325414, annual_avg_emplvl 46853
- Figure 14
QCEW 2020 annual_avg_emplvl 38064; 2025 annual_avg_emplvl 46853
- Figure 15
QCEW 2025 annual, US000, private, NAICS 325414, avg_annual_pay 124162
- Figure 12
- U.S. National Library of Medicine: ClinicalTrials.gov API v2, condition "gene therapy" (2026-11-04)
Quoted lines
- Figure 16
query.cond=gene therapy totalCount 2011
- Figure 16
- U.S. National Library of Medicine: ClinicalTrials.gov API v2, condition "gene therapy", status recruiting (2026-11-04)
Quoted lines
- Figure 17
filter.overallStatus=RECRUITING totalCount 377
- Figure 17
- U.S. National Library of Medicine: PubMed search "cell and gene therapy"[tiab] AND 2025[dp] (2026-11-04)
Quoted lines
- Figure 18
esearch count 118
- Figure 18
Buyers and suppliers
Who buys
- Hospitals and treatment centers
- Specialty pharmacies
- Payers and health systems
Large non-EU suppliers to the EU
What the full report covers
- 01Executive summary
The answer in one page: size, direction and what moves it - 02Market definition and scope
What is in and out of the European Union market - 03Market size, 2021 to 2025
Historical series and growth rates - 04Outlook to 2031
Base, low and high scenarios with stated assumptions - 05Rules, policy and deadlines
Regulation and programmes that change demand - 06Drivers and barriers
What accelerates or slows adoption, by customer segment - 07Prices, costs and margins
Unit economics where public data allows - 08Competitive landscape
8 to 12 company profiles with recent moves - 09Opportunities and risks
For new entrants, suppliers and investors - 10Method and sources
Every assumption and source, listed
Included with the full report
- PDF report, 40 to 60 pages
- Excel data pack
- Ready-to-use charts
- Method note and assumptions
- Written to order in 5 working days
Frequently asked questions
How big is the EU cell and gene therapy market?
There is no single official market total. Eurostat trade data shows the EU imported €662.9 million of goods under CN 30025100 from outside the EU in 2025 and exported €314.0 million.
Where does the EU import cell and gene therapy from?
United States was the largest non-EU supplier in 2025. Other large suppliers included Switzerland, United Kingdom, China.
What is the average import price of cell and gene therapy in the EU?
Dividing Eurostat import value by weight gives about €10,949.99 per kilogram for CN 30025100 in 2025.
Which EU countries export the most cell and gene therapy?
Netherlands led EU exports to non-EU countries in 2025, followed by Italy, Germany.
How many clinical trials study gene therapy?
ClinicalTrials.gov lists 2,011 registered studies.
How many US companies are in the cell and gene therapy industry?
BLS counts 830 private establishments in NAICS 325414 (Biological product (except diagnostic) manufacturing), the closest official industry.
Ask about this market
Ask about a figure, its source, a definition or the editions. Answers use only what is published on this page and the rest of the site, and link to the original source.
- Where does the 662.9 figure for the Cell and gene therapy Market come from?
- How big is the Cell and gene therapy Market?
- What does the Cell and gene therapy Market cover?
- Who are the largest suppliers in the Cell and gene therapy Market?
Answers come from the figures published on this site. Check the linked sources before relying on a number.
Free sample
Get a free sample of this report
We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.
- Full table of contents
- Two sample chapters
- Method note and data outline